Protonix
These highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets, for oral usePROTONIX (pantoprazole sodium) for delayed-release oral suspensionInitial U.S. approval: 2000
08098cb2-c048-4640-f387-6beec4a38936
HUMAN PRESCRIPTION DRUG LABEL
Jun 30, 2023
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
DUNS: 113008515
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
PANTOPRAZOLE SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
PANTOPRAZOLE SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
PANTOPRAZOLE SODIUM
Product Details
FDA regulatory identification and product classification information